Showing results (61-70 of 262) with videos related to
Sort By:
Pageof 27
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 1, 1990
[Interleukin 2: immunologic background and clinical use in tumor therapy]R Dummer, H Welters, U Keilholz, et al.Onkologie|September 7, 2004
The spectrum of mesenchymal skin neoplasms reflected by the new WHO classificationM Beyeler, W Kempf, J Hafner, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 1, 1996
Circulating interleukin-2 receptors are a group of multimeric proteins with immunoreactivity for interleukin-2 receptor alpha, beta, and gamma chainsR Dummer, G Posseckert, K Sugamura, et al.Onkologie|September 16, 2003
Therapy of cutaneous lymphoma--current practice and future developmentsR Dummer, W Kempf, M Hess Schmid, et al.Archives of Dermatology|October 16, 1999
Tumor burden index as a prognostic tool for cutaneous T-cell lymphoma: a new conceptM H Schmid, P Bird, R Dummer, et al.International Journal of Molecular Medicine|December 29, 1998
Immune escape mechanisms in malignant melanomaR Geertsen, G Hofbauer, J Kamarashev, et al.Melanoma Research|October 9, 1998
Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distributionG F Hofbauer, J Kamarashev, R Geertsen, et al.The British Journal of Dermatology|November 18, 2003
Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more?D V Kazakov, T Mentzel, G Burg, et al.Dermatology (Basel, Switzerland)|September 11, 2001
Swiss guidelines for the treatment and follow-up of cutaneous melanomaR Dummer, U Bösch, R Panizzon, et al.Archives of Dermatology|March 21, 2000
Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphomaL Heinzerling, R Dummer, W Kempf, et al.Pageof 27